Updated: January 4, 2026
Emsam Shortage Update: What Patients Need to Know in 2026
Author
Peter Daggett

Summarize with AI
Is there an Emsam shortage in 2026? Here's the latest update on selegiline patch availability, what's causing access issues, and what patients can do now.
Patients trying to fill Emsam (selegiline transdermal system) prescriptions in 2026 are frequently encountering delays, pharmacy confusion, and difficulty locating the medication — leading many to wonder: is there an Emsam shortage?
The short answer is: Emsam is not on the FDA's official drug shortage list as of 2026. But the practical reality is more complicated. Here's what patients need to know.
Current Emsam Availability Status (2026)
As of 2026, the FDA's drug shortage database does not list Emsam in shortage. Viatris (the current manufacturer, via its Mylan Specialty division) continues to produce and distribute all three strengths of the patch: 6 mg/24hr, 9 mg/24hr, and 12 mg/24hr.
However, many patients report being unable to fill their prescriptions at retail pharmacies — or having to wait days to receive their medication. This isn't a manufacturing shortage; it's an access problem rooted in how Emsam is distributed and reimbursed.
Why Patients Are Having Trouble Getting Emsam
There are several structural reasons that create real-world access challenges for Emsam patients in 2026:
Low prescription volume: Emsam accounts for less than 1% of antidepressant prescriptions. Most retail pharmacies don't stock low-volume specialty drugs.
Brand-only, no generic: No FDA-approved generic exists for the selegiline patch. Retail pharmacies prefer to stock drugs they can substitute with generics.
Prior authorization requirements: Most insurers require prior authorization — and often step therapy — before approving Emsam. This delays initial fills.
Specialty pharmacy routing: Many insurance plans require Emsam to be dispensed only through designated specialty pharmacies, which patients may not be aware of.
High cost barrier: At $2,600+ per month retail, even some covered patients face high cost sharing that delays or prevents them from picking up prescriptions.
Has Emsam Ever Had an Official FDA Shortage?
Emsam has not had a widely documented FDA-listed drug shortage in its history dating back to its 2006 approval. The medication's availability challenges are structural rather than supply-chain driven. This distinguishes it from drugs like semaglutide (Ozempic/Wegovy) or ADHD medications that experienced actual manufacturing or demand-driven shortages.
That said, individual patients may experience what feels like a shortage — because their pharmacy doesn't carry it, their insurer doesn't cover it easily, or the logistics of specialty pharmacy routing create delays.
What Patients Can Do Right Now
If you're struggling to fill your Emsam prescription, here are practical steps:
Use medfinder: medfinder.com calls pharmacies near you to find which ones can fill your Emsam prescription and texts you the results.
Contact your insurance company: Ask which specialty pharmacy your plan uses for Emsam and whether mail-order is available.
Get the Emsam Savings Card: Commercially insured patients can use the Viatris Savings Card to pay as little as $20/month, which may open up more pharmacy options.
Ask your doctor about a prior authorization appeal: If your insurer denied coverage, your prescriber can submit documentation supporting medical necessity.
Check patient assistance programs: Uninsured or underinsured patients may qualify for assistance through Prescription Hope (~$70/month) or The Rx Advocates (~$80/month).
Will Emsam Become Easier to Find in the Future?
A generic version of the Emsam patch is not expected until around 2035, when current patent protections are estimated to expire. Until a generic is available, the structural barriers to access (high cost, low volume, specialty routing) will likely remain in place. However, growing recognition of treatment-resistant depression as a clinical priority may increase prescriber adoption and pharmacy stocking over time.
The Bottom Line for Patients
Emsam is available — it is manufactured and distributed — but getting it requires knowing where to look. Understanding that this is an access challenge (not a manufacturing shortage) helps you focus your energy on the right solutions: specialty pharmacies, mail-order, savings programs, and tools like medfinder. Read our guide on how to find Emsam in stock near you for detailed steps.
Frequently Asked Questions
As of 2026, Emsam (selegiline transdermal system) is not listed on the FDA's official drug shortage database. However, many patients experience difficulty filling prescriptions due to low pharmacy stock levels, prior authorization requirements, and specialty pharmacy routing requirements — which can feel like a shortage.
Most retail pharmacies don't stock Emsam because it has very low prescription volume (less than 1% of all antidepressants). Your pharmacy may need to special-order it (1–3 business days), or your insurance may require you to use a specialty pharmacy. Contact your insurer to find out which pharmacies are authorized to dispense Emsam for your plan.
Emsam has not had a widely documented FDA-listed manufacturing shortage since its 2006 approval. Its access challenges are structural (high cost, low volume, specialty routing) rather than supply-chain driven.
No generic for the Emsam patch is available as of 2026. A generic is not expected until approximately 2035, when current patent protections are estimated to expire. Until then, patients must use the brand-name product.
Call your prescribing doctor right away. Do not abruptly stop Emsam without guidance. Your doctor may be able to authorize an emergency supply, adjust your treatment plan temporarily, or connect you with a pharmacy that has stock. Never switch to another antidepressant without a proper MAOI washout period under medical supervision.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Emsam also looked for:
More about Emsam
35,524 have already found their meds with Medfinder.
Start your search today.





